News

Article

FDA Releases Pulmonary Tuberculosis Guidance

FDA releases guidance on pulmonary tuberculosis drugs.

FDA has released a draft guidance, Pulmonary Tuberculosis: Developing Drugs for Treatment, to assist sponsors in the clinical development of drugs for the treatment of pulmonary tuberculosis. The guidance document addresses the overall development program and clinical trial designs for drugs to support an indication for the treatment of active pulmonary tuberculosis. The guidance applies to the development of a single investigational drug as well as to the development of two or more new investigational drugs for use in combination.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Related Content